Heregulin Co-opts PR Transcriptional Action Via Stat3 Role As a Coregulator to Drive Cancer Growth

Area of Science:

• Oncology
• Molecular Biology
• Cell Signaling

Background:

• Bidirectional interactions exist between progesterone receptor (PR) and ErbB receptor tyrosine kinase pathways in breast cancer.
• Signal transducer and activator of transcription 3 (Stat3) was previously identified as a convergence point between PR and ErbB signaling.
• Stat3 activation by heregulin-beta1 (HRGβ1) involves ErbB2 and the co-option of PR as a signaling molecule.

Purpose of the Study:

• To investigate the role of Stat3 in mediating HRGβ1-induced PR activity and breast cancer growth.
• To elucidate the functional consequences of Stat3 recruitment to PR-regulated promoters.
• To understand the context-dependent transcriptional functions of PR modulated by Stat3.

Main Methods:

• Chromatin immunoprecipitation assays to assess Stat3 and PR binding to target gene promoters.
• Analysis of Stat3's effect on PR activity at different promoter sites (Bcl-XL, p21(CIP1), c-myc, and mouse mammary tumor virus).
• In vivo studies to evaluate the necessity of Stat3 for HRGβ1-induced tumor growth.

Main Results:

• HRGβ1 induced Stat3 recruitment to promoters of progestin-regulated genes (Bcl-XL, p21(CIP1)) and the mouse mammary tumor virus promoter.
• HRGβ1-activated Stat3 exhibited differential functions: required for PR binding at c-myc, bcl-X, and p21(CIP1) promoters, but acted as a coactivator for PR at the mouse mammary tumor virus promoter.
• Stat3 was essential for HRGβ1-induced tumor growth in vivo.

Conclusions:

• Stat3 functions as a novel coregulator of HRGβ1-activated PR, promoting breast cancer growth.
• The findings highlight the complex, context-dependent transcriptional actions of PR.
• Understanding the interplay between PR, Stat3, and ErbB signaling is critical for breast cancer therapy.